Specialty Chemicals

PhiChem

PhiChem released FY2025 Q4 earnings on April 21 After-Market (BJT), actual revenue CNY 883.77 M, actual EPS CNY 0.1799

PhiChem released FY2026 Q1 earnings on April 21 After-Market (BJT), actual revenue CNY 872.73 M, actual EPS CNY 0.23

PhiChem released FY2025 Annual Earnings on April 21 After-Market (BJT), actual revenue CNY 3.226 B (forecast CNY 3.072 B), actual EPS CNY 0.71 (forecast CNY 0.66)

PhiChem to Release FY2026 Q1 Earnings on April 22 After-Market (BJT)

PhiChem to Release FY2025 Earnings on April 22 After-Market (BJT), Forecast Revenue CNY 3.072 B, EPS CNY 0.66

PhiChem released FY2025 Q3 earnings on October 29 After-Market (BJT), actual revenue CNY 879.54 M, actual EPS CNY 0.1385

PhiChem released FY2025 9 Months Earnings on October 29 After-Market BJT, actual revenue CNY 2.342 B, actual EPS CNY 0.5327

PhiChem to Release FY2025 Q3 Earnings on October 30 After-Market (BJT)

PhiChem released FY2025 Semi-Annual earnings on August 27 After-Market (BJT), actual revenue CNY 1.462 B, actual EPS CNY 0.39

PhiChem released FY2025 Q2 earnings on August 27 After-Market (BJT), actual revenue CNY 761.72 M, actual EPS CNY 0.1641

PhiChem to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)

Fukai's Subsidiary Suzhou Kai Xing Groundbreaking, 3D Printing Applications Expanding

FK Materials Wholly-Owned Subsidiary Heng Cheng Display Buys JNC Suzhou Equity and Patents

Feikai Materials Responds No Electronic Skin R&D

Feikai Materials Reveals R&D Achievements and Future Direction for 2024

Fukai Materials Reports 100.10% YOY Q1 2025 Net Profit Growth

Feikai Materials Announces 2024 Financial Report and Dividend Plan

PhiChem released FY2025 Q1 earnings on April 22 After-Market (BJT), actual revenue CNY 700.63 M, actual EPS CNY 0.23

PhiChem released FY2024 Q4 earnings on April 22 After-Market (BJT), actual revenue CNY 746.69 M, actual EPS CNY 0.079

PhiChem released FY2024 annual earnings on April 22 After-Market (BJT), actual revenue CNY 2.918 B (forecast CNY 2.962 B), actual EPS CNY 0.47 (forecast CNY 0.68)

300398

300537

China's first EUV photoresist standard, "Extreme Ultraviolet Photoresist Testing Methods," was publicly announced on October 23, aiming to fill the gap in domestic technical standards and provide a unified testing method for the performance evaluation of EUV photoresists. In the A-share market, there are more than 20 photoresist concept stocks, with 6 companies reporting good performance in their third-quarter reports. 11 concept stocks have been investigated by 13 or more institutions this year, with PhiChem and KUANGSHUN MATERIAL among the companies with the highest number of research institutions

Zhitong

KUANGSHUN MATERIAL

The EUV photoresist standard is proposed for project initiation, with a list of leading photoresist concept stocks based on the number of research institutions surveyed this year

PhiChem announced that the company's deputy general manager Song Shuguo has reduced his holdings by 128,400 shares through centralized bidding from October 9, 2025, to October 10, 2025, at an average price of 25.78 yuan/share, accounting for 0.02% of the company's total share capital; this reduction plan has been completed, and after the reduction, he holds 385,100 shares, accounting for 0.07%

PhiChem: Vice President Song Shuguo has reduced his holdings by 0.02%

PhiChem stated on the interactive platform that the company has produced i-line photoresist and KrF photoresist supporting BARC materials for the semiconductor field, both of which have now achieved stable mass production

PhiChem: The company produces i-line photoresists and other materials used in the semiconductor field

According to the Zhitong Finance APP, PhiChem released its semi-annual report for 2025, with operating revenue of 1.462 billion yuan, a year-on-year increase of 3.80%. The net profit attributable to shareholders of the listed company was 217 million yuan, a year-on-year increase of 80.45%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 176 million yuan, a year-on-year increase of 40.47%. The basic earnings per share were 0.39 yuan

PhiChem released its performance for the first half of the year, with a net profit attributable to the parent company of 217 million yuan, an increase of 80.45%

According to the Qichacha APP, recently, Anqing Longkai New Materials Technology Co., Ltd. was established, with Qiu Xiaosheng as the legal representative and a registered capital of 10 million yuan. The business scope includes: sales of synthetic materials; sales of bio-based materials; research and development of bio-based material technology; research and development of bio-based material polymerization technology; manufacturing of bio-based materials, etc. Qichacha's equity penetration shows that the company is wholly owned by PhiChem indirectly

PhiChem establishes a new company, including biobased materials manufacturing business

688571

600895

002324

In the A-share market, photolithography concept stocks rose, with Wavelength Opto-Electronic up over 9%, ZJHTC up over 7%, HANGZHOU TOKA and Taihe Technology up over 5%, PRET, HaLi Co., and PhiChem up over 4%, Guolin Technology, Maolai Optics, and Lanying Equipment up over 3%

HANGZHOU TOKA

ZJHTC

PRET

A-share photolithography concept stocks rose, ZJHTC increased by over 7%

PhiChem's wholly-owned subsidiary Jiangsu Hecheng Display Technology Co., Ltd. plans to purchase 100% equity of JNC Suzhou for 170 million yuan and acquire all display-related patents from JNC Group for 212 million yuan. JNC will subscribe to Hecheng Display's increased registered capital for 170 million yuan, obtaining a 5.10% equity stake. This transaction aims to optimize the industrial structure, strengthen resource integration, consolidate the company's core competitiveness, align with long-term development plans, and will not have a significant adverse impact on the company's operating results and financial condition

PhiChem's subsidiary plans to acquire 100% equity of JNC Suzhou and all patents related to display liquid crystals owned by the JNC Group

On May 13th, PhiChem stated on the interactive platform that the company currently does not have products directly applied to humanoid robots. The company will closely monitor market dynamics and customer needs, and is ready to provide suitable products and services based on customer production requirements at any time

PhiChem: Currently, there are no products directly applied to humanoid robots

688199

300429

300200

002549

300260

KAIMEITE GASES hit the upper limit, PhiChem rose over 10%, KINGLAI MATERIALS, Jiuri, TRONLY, Comens Materials, and Yida Co., Ltd. all rose over 5%

Jiuri

TRONLY

Comens Materials

KAIMEITE GASES

KINGLAI MATERIALS

YIDA

The concept of photolithography machines and photoresists fluctuates and rises, KAIMEITE GASES hits the limit up

PhiChem released its 2024 annual report, with operating revenue of 2.918 billion yuan, a year-on-year increase of 6.92%; net profit attributable to shareholders of the parent company was 247 million yuan, a year-on-year increase of 119.42%; net profit excluding non-recurring gains and losses was 240 million yuan, a year-on-year increase of 379.65%. The basic earnings per share were 0.47 yuan, and it plans to distribute a cash dividend of 0.65 yuan (including tax) for every 10 shares to all shareholders

PhiChem released its 2024 annual performance, with a net profit attributable to the parent company of 247 million yuan, an increase of 119.42%

PhiChem(300398.SZ)